Press
Founding Managing Partner William Dai was profiled discussing what separates successful medtech startups, tied to LSI USA '26.
William Dai on the discipline of building medtech winners (LSI USA '26)
APR 28, 2026
Investment
Participated in Nervonik's oversubscribed $52.5M Series B for peripheral nerve stimulation, led by Amzak Health.
Nervonik
NervonikShangBay Capital
APR 27, 2026
Investment
Participated in Laplace Interventional's $22M Series C to advance its transcatheter tricuspid valve technology.
Laplace Interventional
Laplace InterventionalShangBay Capital
MAR 16, 2025
Investment
Participated in Abcuro's $200M Series C, led by NEA, to advance its inclusion body myositis treatment.
Abcuro
FEB 12, 2025
Investment
Participated in Zeto's $31M Series B, led by MindWorks Global, for EEG brain monitoring.
Zeto
ZetoShangBay Capital
JAN 8, 2025
Investment
Participated in Fluid Biomed's oversubscribed $27M Series A for a bioabsorbable brain aneurysm stent.
Fluid Biomed
Fluid BiomedShangBay Capital
DEC 16, 2024
Investment
Participated in Zenflow's $24M Series C, led by Cook Medical, for its benign prostatic hyperplasia treatment.
Zenflow
NOV 18, 2024